acetylcarnitine has been researched along with Disease Models, Animal in 68 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic treatment with acetyl-L-carnitine (ALCAR) prevents the neuropathic pain syndrome that is evoked by the chemotherapeutic agent, paclitaxel." | 7.74 | Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. ( Bennett, GJ; Flatters, SJ; Jin, HW; Mulhern, HL; Xiao, WH, 2008) |
| "Epilepsy is a prevalent neurological disease, affecting approximately 1-2% of the global population." | 5.91 | Effects of N-acetylcysteine and acetyl-L-carnitine on acute PTZ-induced seizures in larval and adult zebrafish. ( Benvenutti, R; Chitolina, R; Herrmann, AP; Linazzi, A; Marcon, M; Piato, A; Reis, CG; Stahlhofer-Buss, T, 2023) |
| " Evidence from animal models of chemotherapy-induced painful peripheral neuropathy produced by the taxane agent, paclitaxel, and the platinum-complex agent, oxaliplatin, indicate that they produce neuropathy via a common mechanism-a toxic effect on the mitochondria in primary afferent sensory neurons." | 5.38 | Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. ( Bennett, GJ; Xiao, WH; Zheng, H, 2012) |
| "Fatigue is an indispensable sense for ordering rest." | 5.31 | Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. ( Evengård, B; Hagberg, G; Iwase, M; Kanakura, Y; Kitani, T; Kuratsune, H; Långström, B; Lindh, G; Machii, T; Matsumura, K; Onoe, H; Takahashi, M; Watanabe, Y; Yamaguti, K, 2002) |
| "The effects of chronic hypoxia on cardiac membrane fatty acids and on lipid peroxidation were examined, as well as the effect of l-carnitine (LCAR), which suppresses lipid peroxidation, on this process." | 3.74 | Change in the membranous lipid composition accelerates lipid peroxidation in young rat hearts subjected to 2 weeks of hypoxia followed by hyperoxia. ( Hamaoka, K; Itoi, T; Nakanishi, H; Oka, T; Taguchi, R; Terada, N, 2008) |
| "Prophylactic treatment with acetyl-L-carnitine (ALCAR) prevents the neuropathic pain syndrome that is evoked by the chemotherapeutic agent, paclitaxel." | 3.74 | Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. ( Bennett, GJ; Flatters, SJ; Jin, HW; Mulhern, HL; Xiao, WH, 2008) |
| "Current therapy of mood disorders has several limitations." | 2.55 | l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug. ( Canonico, PL; Chiechio, S; Grilli, M, 2017) |
| "Epilepsy is a prevalent neurological disease, affecting approximately 1-2% of the global population." | 1.91 | Effects of N-acetylcysteine and acetyl-L-carnitine on acute PTZ-induced seizures in larval and adult zebrafish. ( Benvenutti, R; Chitolina, R; Herrmann, AP; Linazzi, A; Marcon, M; Piato, A; Reis, CG; Stahlhofer-Buss, T, 2023) |
| "ALC properly attenuated intensity of seizures and also incidence of kainate-induced status epilepticus (SE)." | 1.72 | Acetyl-L-Carnitine Exerts Neuroprotective and Anticonvulsant Effect in Kainate Murine Model of Temporal Lobe Epilepsy. ( Baluchnejadmojarad, T; Hashemi, P; Nazari-Serenjeh, M; Ramazi, S; Roghani, M; Tashakori-Miyanroudi, M, 2022) |
| "Pancreatitis was induced with 6 hly intraperitoneal (i." | 1.62 | Effect of acetyl-L-carnitine on hypersensitivity in acute recurrent caerulein-induced pancreatitis and microglial activation along the brain's pain circuitry. ( High, AE; McIlwrath, SL; Saito, H; Starr, ME; Westlund, KN, 2021) |
| "L-acetylcarnitine treatment enhanced mGlu2/3 receptor protein levels in the dorsal region of the spinal cord." | 1.46 | Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain. ( Battaglia, G; Bernabucci, M; Bruno, V; Cannella, M; Gradini, R; Imbriglio, T; Mascio, G; Nicoletti, F; Notartomaso, S; Scarselli, P; Zappulla, C, 2017) |
| "Neuroinflammation is the inflammation of nervous tissue that can lead to neurodegeneration." | 1.46 | Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor. ( Kazak, F; Yarim, GF, 2017) |
| "Neuroinflammation was induced by lipopolysaccharide (LPS)." | 1.46 | Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor. ( Kazak, F; Yarim, GF, 2017) |
| " Despite intensive research, the quest for promising neuroprotective drugs has largely failed, not only because of ineffectiveness, but also because of serious side-effects and dosing difficulties." | 1.40 | Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia. ( Farkas, T; Gellért, L; Iwamori, N; Kis, Z; Knapp, L; Kocsis, K; Oláh, G; Ono, E; Takakuwa, H; Toldi, J, 2014) |
| "Pain was measured in animals submitted to MIA model by paw pressure and compression behavioral tests in the presence or absence of ALC." | 1.40 | Prophylactic role of acetyl-l-carnitine on knee lesions and associated pain in a rat model of osteoarthritis. ( Aglianò, M; Bianchi, E; Di Cesare Mannelli, L; Ghelardini, C; Lorenzoni, P; Menicacci, C, 2014) |
| "The development of pulmonary hypertension is a common accompaniment of congenital heart disease (CHD) with increased pulmonary blood flow." | 1.38 | Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I. ( Aramburo, A; Black, SM; Fineman, JR; Kalkan, G; Kallarackal, S; Kumar, S; Rafikov, R; Rehmani, I; Sharma, S; Sun, X; Tian, J, 2012) |
| " Evidence from animal models of chemotherapy-induced painful peripheral neuropathy produced by the taxane agent, paclitaxel, and the platinum-complex agent, oxaliplatin, indicate that they produce neuropathy via a common mechanism-a toxic effect on the mitochondria in primary afferent sensory neurons." | 1.38 | Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy. ( Bennett, GJ; Xiao, WH; Zheng, H, 2012) |
| " Female Wistar Hanover rats were dosed daily for 12 days (oral gavage) with either vehicle (control, 0." | 1.38 | Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. ( Constantin-Teodosiu, D; Davies, WJ; Glaves, PD; Greenhaff, PL; Mallinson, JE; Martin, EA; Sidaway, JE; Westwood, FR, 2012) |
| "ALCAR completely prevented mechanical hyperalgesia and provoked in the nerve a c-Jun increment only." | 1.36 | The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain. ( Bartolini, A; Di Cesare Mannelli, L; Ghelardini, C; Pacini, A; Toscano, A, 2010) |
| " The inhibition of TNF-alpha could be improved by ALC and in a dose-response relation." | 1.36 | [Effect of acetyl-L-carnitine on the insulin resistance of L6 cells induced by tumor necrosis factor-alpha]. ( Dai, X; Ding, Y; Li, Y; Wang, J; Zhang, Z; Zhao, M, 2010) |
| "Caerulein induced acute pancreatitis that was well-characterized morphologically and biochemically." | 1.35 | Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats. ( Abdel-Wahab, MH; Arafa, HM; Badary, OA; Hamada, FM; Hassan, MI; Hemeida, RA, 2009) |
| " Compared to a saline-injected control group, chronic administration of ALCAR at doses of 10 and 100 mg/kg (tested 24 h after the last dose administration) showed no effects, whereas doses of 50 and 75 mg/kg significantly reduced anxiety-like behaviours in the elevated plus-maze." | 1.33 | Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats. ( Buriakovsky, I; Cohen, H; Gershon, S; Kaplan, Z; Levine, J; McClure, RJ; Pettegrew, JW, 2005) |
| "Treatment with acetylcarnitine (AcCN) increases the activity of cytochrome oxidase in the aged heart." | 1.33 | Reversal of mitochondrial defects before ischemia protects the aged heart. ( He, D; Hoppel, CL; Lesnefsky, EJ; Moghaddas, S, 2006) |
| "Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
| "Fatigue is an indispensable sense for ordering rest." | 1.31 | Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. ( Evengård, B; Hagberg, G; Iwase, M; Kanakura, Y; Kitani, T; Kuratsune, H; Långström, B; Lindh, G; Machii, T; Matsumura, K; Onoe, H; Takahashi, M; Watanabe, Y; Yamaguti, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.47) | 18.7374 |
| 1990's | 3 (4.41) | 18.2507 |
| 2000's | 21 (30.88) | 29.6817 |
| 2010's | 37 (54.41) | 24.3611 |
| 2020's | 6 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Tashakori-Miyanroudi, M | 1 |
| Ramazi, S | 1 |
| Hashemi, P | 1 |
| Nazari-Serenjeh, M | 1 |
| Baluchnejadmojarad, T | 1 |
| Roghani, M | 1 |
| Wang, J | 2 |
| Song, J | 1 |
| Song, G | 1 |
| Feng, Y | 1 |
| Pan, J | 1 |
| Yang, X | 1 |
| Xin, Z | 1 |
| Hu, P | 1 |
| Sun, T | 1 |
| Liu, K | 1 |
| Xu, W | 1 |
| Wang, T | 1 |
| Wang, S | 1 |
| Liu, J | 5 |
| Ruan, Y | 1 |
| Qutob, HMH | 1 |
| Saad, RA | 1 |
| Bali, H | 1 |
| Osailan, A | 1 |
| Jaber, J | 1 |
| Alzahrani, E | 1 |
| Alyami, J | 1 |
| Elsayed, H | 1 |
| Alserihi, R | 1 |
| Shaikhomar, OA | 1 |
| Divya, KM | 1 |
| Savitha, DP | 1 |
| Krishna, GA | 1 |
| Dhanya, TM | 1 |
| Mohanan, PV | 1 |
| Shah, SF | 1 |
| Jafry, AT | 1 |
| Hussain, G | 1 |
| Kazim, AH | 1 |
| Ali, M | 1 |
| Rivani, E | 1 |
| Endraswari, PD | 1 |
| Widodo, ADW | 1 |
| Khalil, MR | 1 |
| Guldberg, R | 1 |
| Nørgård, BM | 1 |
| Uldbjerg, N | 1 |
| Wehberg, S | 1 |
| Fowobaje, KR | 1 |
| Mashood, LO | 1 |
| Ekholuenetale, M | 1 |
| Ibidoja, OJ | 1 |
| Romagnoli, A | 1 |
| D'Agostino, M | 1 |
| Pavoni, E | 1 |
| Ardiccioni, C | 1 |
| Motta, S | 1 |
| Crippa, P | 1 |
| Biagetti, G | 1 |
| Notarstefano, V | 1 |
| Rexha, J | 1 |
| Perta, N | 1 |
| Barocci, S | 1 |
| Costabile, BK | 1 |
| Colasurdo, G | 1 |
| Caucci, S | 1 |
| Mencarelli, D | 1 |
| Turchetti, C | 1 |
| Farina, M | 1 |
| Pierantoni, L | 1 |
| La Teana, A | 1 |
| Al Hadi, R | 1 |
| Cicconardi, F | 1 |
| Chinappi, M | 1 |
| Trucchi, E | 1 |
| Mancia, F | 1 |
| Menzo, S | 1 |
| Morozzo Della Rocca, B | 1 |
| D'Annessa, I | 1 |
| Di Marino, D | 1 |
| Choya, A | 1 |
| de Rivas, B | 1 |
| Gutiérrez-Ortiz, JI | 1 |
| López-Fonseca, R | 1 |
| Xu, S | 2 |
| Cheng, B | 1 |
| Huang, Z | 1 |
| Liu, T | 1 |
| Li, Y | 2 |
| Jiang, L | 1 |
| Guo, W | 1 |
| Xiong, J | 1 |
| Amirazodi, M | 1 |
| Daryanoosh, F | 1 |
| Mehrabi, A | 1 |
| Gaeini, A | 1 |
| Koushkie Jahromi, M | 1 |
| Salesi, M | 1 |
| Zarifkar, AH | 1 |
| Studeny, P | 1 |
| Netukova, M | 1 |
| Nemcokova, M | 1 |
| Klimesova, YM | 1 |
| Krizova, D | 1 |
| Kang, H | 2 |
| Tao, Y | 1 |
| Zhang, Q | 1 |
| Sha, D | 1 |
| Chen, Y | 1 |
| Yao, J | 1 |
| Gao, Y | 1 |
| Ji, L | 1 |
| Shi, P | 1 |
| Shi, C | 1 |
| Wu, YL | 1 |
| Wright, AI | 1 |
| M El-Metwaly, N | 1 |
| A Katouah, H | 1 |
| El-Desouky, MG | 1 |
| El-Bindary, AA | 1 |
| El-Bindary, MA | 1 |
| Kostakis, ID | 1 |
| Raptis, DA | 1 |
| Davidson, BR | 1 |
| Iype, S | 1 |
| Nasralla, D | 1 |
| Imber, C | 1 |
| Sharma, D | 1 |
| Pissanou, T | 1 |
| Pollok, JM | 1 |
| Hughes, AM | 1 |
| Sanderson, E | 1 |
| Morris, T | 1 |
| Ayorech, Z | 1 |
| Tesli, M | 1 |
| Ask, H | 1 |
| Reichborn-Kjennerud, T | 1 |
| Andreassen, OA | 1 |
| Magnus, P | 1 |
| Helgeland, Ø | 1 |
| Johansson, S | 1 |
| Njølstad, P | 1 |
| Davey Smith, G | 1 |
| Havdahl, A | 1 |
| Howe, LD | 1 |
| Davies, NM | 1 |
| Amrillah, T | 1 |
| Prasetio, A | 1 |
| Supandi, AR | 1 |
| Sidiq, DH | 1 |
| Putra, FS | 1 |
| Nugroho, MA | 1 |
| Salsabilla, Z | 1 |
| Azmi, R | 1 |
| Grammatikopoulos, P | 1 |
| Bouloumis, T | 1 |
| Steinhauer, S | 1 |
| Mironov, VS | 2 |
| Bazhenova, TA | 2 |
| Manakin, YV | 2 |
| Yagubskii, EB | 2 |
| Yakushev, IA | 1 |
| Gilmutdinov, IF | 1 |
| Simonov, SV | 1 |
| Lan, K | 1 |
| Yang, H | 1 |
| Zheng, J | 2 |
| Hu, H | 1 |
| Zhu, T | 1 |
| Zou, X | 1 |
| Hu, B | 1 |
| Liu, H | 2 |
| Olokede, O | 1 |
| Wu, H | 1 |
| Holtzapple, M | 1 |
| Gungor, O | 1 |
| Kose, M | 1 |
| Ghaemi, R | 1 |
| Acker, M | 1 |
| Stosic, A | 1 |
| Jacobs, R | 1 |
| Selvaganapathy, PR | 1 |
| Ludwig, N | 1 |
| Yerneni, SS | 1 |
| Azambuja, JH | 1 |
| Pietrowska, M | 1 |
| Widłak, P | 1 |
| Hinck, CS | 1 |
| Głuszko, A | 1 |
| Szczepański, MJ | 1 |
| Kärmer, T | 1 |
| Kallinger, I | 1 |
| Schulz, D | 1 |
| Bauer, RJ | 1 |
| Spanier, G | 1 |
| Spoerl, S | 1 |
| Meier, JK | 1 |
| Ettl, T | 1 |
| Razzo, BM | 1 |
| Reichert, TE | 1 |
| Hinck, AP | 1 |
| Whiteside, TL | 1 |
| Wei, ZL | 1 |
| Juan, W | 1 |
| Tong, D | 1 |
| Juan, LX | 1 |
| Sa, LY | 1 |
| Jie, HFM | 1 |
| Xiao, G | 1 |
| Xiang, LG | 1 |
| Jie, HM | 1 |
| Xu, C | 1 |
| Yu, DN | 1 |
| Yao, ZX | 1 |
| Bigdeli, F | 1 |
| Gao, XM | 1 |
| Cheng, X | 1 |
| Li, JZ | 1 |
| Zhang, JW | 1 |
| Wang, W | 3 |
| Guan, ZJ | 1 |
| Bu, Y | 1 |
| Liu, KG | 1 |
| Morsali, A | 1 |
| Das, R | 1 |
| Paul, R | 1 |
| Parui, A | 1 |
| Shrotri, A | 1 |
| Atzori, C | 1 |
| Lomachenko, KA | 1 |
| Singh, AK | 1 |
| Mondal, J | 1 |
| Peter, SC | 1 |
| Florimbio, AR | 1 |
| Coughlin, LN | 1 |
| Bauermeister, JA | 1 |
| Young, SD | 1 |
| Zimmerman, MA | 1 |
| Walton, MA | 1 |
| Bonar, EE | 1 |
| Demir, D | 1 |
| Balci, AB | 1 |
| Kahraman, N | 1 |
| Sunbul, SA | 1 |
| Gucu, A | 1 |
| Seker, IB | 1 |
| Badem, S | 1 |
| Yuksel, A | 1 |
| Ozyazicioglu, AF | 1 |
| Goncu, MT | 1 |
| Zhang, H | 1 |
| Zhou, H | 1 |
| Deng, Z | 1 |
| Luo, L | 1 |
| Ong, SP | 1 |
| Wang, C | 2 |
| Xin, H | 1 |
| Whittingham, MS | 1 |
| Zhou, G | 1 |
| Maemura, R | 1 |
| Wakamatsu, M | 1 |
| Matsumoto, K | 1 |
| Sakaguchi, H | 1 |
| Yoshida, N | 1 |
| Hama, A | 1 |
| Yoshida, T | 1 |
| Miwata, S | 1 |
| Kitazawa, H | 1 |
| Narita, K | 1 |
| Kataoka, S | 1 |
| Ichikawa, D | 1 |
| Hamada, M | 1 |
| Taniguchi, R | 1 |
| Suzuki, K | 1 |
| Kawashima, N | 1 |
| Nishikawa, E | 1 |
| Narita, A | 1 |
| Okuno, Y | 1 |
| Nishio, N | 1 |
| Kato, K | 1 |
| Kojima, S | 1 |
| Morita, K | 1 |
| Muramatsu, H | 1 |
| Takahashi, Y | 1 |
| Yirgu, A | 1 |
| Mekonnen, Y | 1 |
| Eyado, A | 1 |
| Staropoli, A | 1 |
| Vinale, F | 1 |
| Zac, J | 1 |
| Zac, S | 1 |
| Pérez-Padilla, R | 1 |
| Remigio-Luna, A | 1 |
| Guzmán-Boulloud, N | 1 |
| Gochicoa-Rangel, L | 1 |
| Guzmán-Valderrábano, C | 1 |
| Thirión-Romero, I | 1 |
| Statsenko, ME | 1 |
| Turkina, SV | 1 |
| Barantsevich, ER | 1 |
| Karakulova, YV | 1 |
| Baranova, NS | 1 |
| Morzhukhina, MV | 1 |
| Wang, Q | 4 |
| Gu, Y | 1 |
| Chen, C | 1 |
| Qiao, L | 1 |
| Pan, F | 1 |
| Song, C | 1 |
| Canetto, SS | 1 |
| Entilli, L | 1 |
| Cerbo, I | 1 |
| Cipolletta, S | 1 |
| Wu, Y | 2 |
| Zhu, P | 1 |
| Jiang, Y | 1 |
| Zhang, X | 1 |
| Wang, Z | 1 |
| Xie, B | 1 |
| Song, T | 1 |
| Zhang, F | 1 |
| Luo, A | 1 |
| Li, S | 1 |
| Xiong, X | 1 |
| Han, J | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Huang, L | 1 |
| Chen, Q | 1 |
| Fang, W | 1 |
| Hou, Y | 1 |
| Zhu, Y | 1 |
| Ye, J | 1 |
| Liu, L | 1 |
| Islam, MR | 1 |
| Sanderson, P | 1 |
| Johansen, MP | 1 |
| Payne, TE | 1 |
| Naidu, R | 1 |
| Cao, J | 1 |
| Yang, J | 1 |
| Niu, X | 1 |
| Liu, X | 1 |
| Zhai, Y | 1 |
| Qiang, C | 1 |
| Niu, Y | 1 |
| Li, Z | 1 |
| Dong, N | 1 |
| Wen, B | 1 |
| Ouyang, Z | 1 |
| Zhang, Y | 2 |
| Li, J | 2 |
| Zhao, M | 2 |
| Zhao, J | 2 |
| Morici, P | 1 |
| Rizzato, C | 1 |
| Ghelardi, E | 1 |
| Rossolini, GM | 1 |
| Lupetti, A | 1 |
| Gözüküçük, R | 1 |
| Cakiroglu, B | 1 |
| He, X | 1 |
| Li, R | 1 |
| Zhao, D | 1 |
| Zhang, L | 2 |
| Ji, X | 1 |
| Fan, X | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Luo, Y | 1 |
| Zheng, D | 1 |
| Xie, L | 1 |
| Sun, S | 1 |
| Cai, Z | 1 |
| Liu, Q | 1 |
| Ma, K | 1 |
| Sun, X | 2 |
| Drinkwater, JJ | 1 |
| Davis, TME | 1 |
| Turner, AW | 1 |
| Davis, WA | 1 |
| Suzuki, Y | 1 |
| Mizuta, Y | 1 |
| Mikagi, A | 1 |
| Misawa-Suzuki, T | 1 |
| Tsuchido, Y | 1 |
| Sugaya, T | 1 |
| Hashimoto, T | 1 |
| Ema, K | 1 |
| Hayashita, T | 1 |
| Chitolina, R | 1 |
| Reis, CG | 1 |
| Stahlhofer-Buss, T | 1 |
| Linazzi, A | 1 |
| Benvenutti, R | 1 |
| Marcon, M | 1 |
| Herrmann, AP | 1 |
| Piato, A | 1 |
| Ardizzone, A | 1 |
| Fusco, R | 1 |
| Casili, G | 1 |
| Lanza, M | 1 |
| Impellizzeri, D | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 1 |
| McIlwrath, SL | 1 |
| Starr, ME | 1 |
| High, AE | 1 |
| Saito, H | 1 |
| Westlund, KN | 1 |
| Notartomaso, S | 1 |
| Mascio, G | 1 |
| Bernabucci, M | 1 |
| Zappulla, C | 1 |
| Scarselli, P | 1 |
| Cannella, M | 1 |
| Imbriglio, T | 1 |
| Gradini, R | 1 |
| Battaglia, G | 1 |
| Bruno, V | 1 |
| Nicoletti, F | 1 |
| Kazak, F | 1 |
| Yarim, GF | 1 |
| Truong, T | 1 |
| Gardner, DK | 1 |
| Chiechio, S | 1 |
| Canonico, PL | 1 |
| Grilli, M | 1 |
| Sung, Y | 1 |
| Spagou, K | 1 |
| Kafeza, M | 1 |
| Kyriakides, M | 1 |
| Dharmarajah, B | 1 |
| Shalhoub, J | 1 |
| Diaz, JA | 1 |
| Wakefield, TW | 1 |
| Holmes, E | 1 |
| Davies, AH | 1 |
| Evans, E | 1 |
| Piccio, L | 1 |
| Cross, AH | 1 |
| Gibbs, KL | 1 |
| Kalmar, B | 1 |
| Rhymes, ER | 1 |
| Fellows, AD | 1 |
| Ahmed, M | 1 |
| Whiting, P | 1 |
| Davies, CH | 1 |
| Greensmith, L | 1 |
| Schiavo, G | 1 |
| Chen, DQ | 1 |
| Cao, G | 1 |
| Chen, H | 1 |
| Argyopoulos, CP | 1 |
| Yu, H | 1 |
| Su, W | 1 |
| Chen, L | 1 |
| Samuels, DC | 1 |
| Zhuang, S | 1 |
| Bayliss, GP | 1 |
| Zhao, S | 1 |
| Yu, XY | 1 |
| Vaziri, ND | 1 |
| Wang, M | 1 |
| Liu, D | 2 |
| Mao, JR | 1 |
| Ma, SX | 1 |
| Shang, YQ | 1 |
| Ye, F | 1 |
| Cheng, XH | 1 |
| Li, XR | 1 |
| Meng, MX | 1 |
| Guo, Y | 1 |
| Zhao, YY | 1 |
| Kathirvel, E | 1 |
| Morgan, K | 1 |
| French, SW | 1 |
| Morgan, TR | 1 |
| Mehrotra, A | 2 |
| Sandhir, R | 2 |
| Karalija, A | 1 |
| Novikova, LN | 1 |
| Kingham, PJ | 1 |
| Wiberg, M | 2 |
| Novikov, LN | 1 |
| Kocsis, K | 2 |
| Knapp, L | 2 |
| Gellért, L | 1 |
| Oláh, G | 1 |
| Kis, Z | 2 |
| Takakuwa, H | 1 |
| Iwamori, N | 1 |
| Ono, E | 1 |
| Toldi, J | 2 |
| Farkas, T | 2 |
| Bianchi, E | 1 |
| Di Cesare Mannelli, L | 4 |
| Menicacci, C | 1 |
| Lorenzoni, P | 1 |
| Aglianò, M | 1 |
| Ghelardini, C | 4 |
| Dodd, MS | 1 |
| Atherton, HJ | 1 |
| Carr, CA | 1 |
| Stuckey, DJ | 1 |
| West, JA | 1 |
| Griffin, JL | 1 |
| Radda, GK | 1 |
| Clarke, K | 1 |
| Heather, LC | 1 |
| Tyler, DJ | 1 |
| Mészáros, J | 1 |
| Vécsei, L | 1 |
| Lu, Y | 1 |
| Xue, Z | 1 |
| Li, C | 1 |
| Zhao, X | 1 |
| Zhang, J | 1 |
| Wei, X | 1 |
| Chen, X | 1 |
| Cui, W | 1 |
| Zhou, W | 1 |
| Singh, S | 1 |
| Mishra, A | 1 |
| Shukla, S | 1 |
| Sood, A | 1 |
| Ewan, EE | 1 |
| Hagg, T | 1 |
| Snigdha, S | 1 |
| de Rivera, C | 1 |
| Milgram, NW | 1 |
| Cotman, CW | 1 |
| Bigio, B | 1 |
| Mathé, AA | 1 |
| Sousa, VC | 1 |
| Zelli, D | 1 |
| Svenningsson, P | 1 |
| McEwen, BS | 1 |
| Nasca, C | 1 |
| Tang, S | 1 |
| Lu, X | 1 |
| Gullapalli, RP | 1 |
| McKenna, MC | 2 |
| Waddell, J | 1 |
| Oka, T | 1 |
| Itoi, T | 1 |
| Terada, N | 1 |
| Nakanishi, H | 1 |
| Taguchi, R | 1 |
| Hamaoka, K | 1 |
| Calvani, M | 1 |
| Nicolai, R | 3 |
| Mosconi, L | 1 |
| Toscano, A | 2 |
| Pacini, A | 2 |
| Bartolini, A | 3 |
| Kostopoulos, VK | 1 |
| Davis, CL | 1 |
| Terzis, JK | 2 |
| Shenk, JC | 1 |
| Fischbach, K | 1 |
| Xu, K | 1 |
| Puchowicz, M | 1 |
| Obrenovich, ME | 1 |
| Gasimov, E | 1 |
| Alvarez, LM | 1 |
| Ames, BN | 1 |
| Lamanna, JC | 1 |
| Aliev, G | 1 |
| Arafa, HM | 1 |
| Hemeida, RA | 1 |
| Hassan, MI | 1 |
| Abdel-Wahab, MH | 1 |
| Badary, OA | 1 |
| Hamada, FM | 1 |
| Kokkalis, ZT | 1 |
| Soucacos, PN | 1 |
| Yin, YY | 1 |
| Cong, XB | 1 |
| Liu, Z | 1 |
| Wang, JZ | 2 |
| Zhu, LQ | 2 |
| Ruggenenti, P | 1 |
| van der Meer, IM | 1 |
| Remuzzi, G | 1 |
| Zhang, Z | 1 |
| Ding, Y | 1 |
| Dai, X | 1 |
| Abdul Muneer, PM | 1 |
| Alikunju, S | 1 |
| Szlachetka, AM | 1 |
| Haorah, J | 1 |
| Scafidi, S | 1 |
| Racz, J | 1 |
| Hazelton, J | 1 |
| Fiskum, G | 3 |
| Vivoli, E | 1 |
| Salvicchi, A | 1 |
| Schiavone, N | 1 |
| Koverech, A | 1 |
| Messano, M | 1 |
| Benatti, P | 1 |
| Zhou, P | 1 |
| Chen, Z | 1 |
| Zhao, N | 1 |
| Guo, ZY | 1 |
| Tan, L | 1 |
| Hu, J | 1 |
| Karsidag, S | 2 |
| Akcal, A | 1 |
| Sahin, S | 1 |
| Kabukcuoglu, F | 1 |
| Ugurlu, K | 1 |
| Du, X | 1 |
| Chen, K | 1 |
| Choi, CH | 1 |
| Li, W | 1 |
| Cheng, W | 1 |
| Stewart, C | 1 |
| Hu, N | 1 |
| Floyd, RA | 1 |
| Kopke, RD | 2 |
| Sharma, S | 1 |
| Kumar, S | 1 |
| Rafikov, R | 1 |
| Aramburo, A | 1 |
| Kalkan, G | 1 |
| Tian, J | 1 |
| Rehmani, I | 1 |
| Kallarackal, S | 1 |
| Fineman, JR | 1 |
| Black, SM | 1 |
| Zheng, H | 1 |
| Xiao, WH | 2 |
| Bennett, GJ | 2 |
| Mallinson, JE | 1 |
| Constantin-Teodosiu, D | 1 |
| Glaves, PD | 1 |
| Martin, EA | 1 |
| Davies, WJ | 1 |
| Westwood, FR | 1 |
| Sidaway, JE | 1 |
| Greenhaff, PL | 1 |
| Schaevitz, LR | 1 |
| Lopez, CM | 1 |
| D'Iddio, S | 1 |
| Iannoni, E | 1 |
| Berger-Sweeney, JE | 1 |
| Ferreira, MR | 1 |
| Camberos, Mdel C | 1 |
| Selenscig, D | 1 |
| Martucci, LC | 1 |
| Chicco, A | 1 |
| Lombardo, YB | 1 |
| Cresto, JC | 1 |
| Pop-Busui, R | 1 |
| Marinescu, V | 1 |
| Van Huysen, C | 1 |
| Li, F | 1 |
| Sullivan, K | 1 |
| Greene, DA | 1 |
| Larkin, D | 1 |
| Stevens, MJ | 1 |
| Coleman, JK | 2 |
| Campbell, KC | 1 |
| Riffenburgh, RH | 1 |
| Kuratsune, H | 1 |
| Yamaguti, K | 1 |
| Lindh, G | 1 |
| Evengård, B | 1 |
| Hagberg, G | 1 |
| Matsumura, K | 1 |
| Iwase, M | 1 |
| Onoe, H | 1 |
| Takahashi, M | 1 |
| Machii, T | 1 |
| Kanakura, Y | 1 |
| Kitani, T | 1 |
| Långström, B | 1 |
| Watanabe, Y | 1 |
| Yasui, F | 1 |
| Matsugo, S | 1 |
| Ishibashi, M | 1 |
| Kajita, T | 1 |
| Ezashi, Y | 1 |
| Oomura, Y | 1 |
| Kojo, S | 1 |
| Sasaki, K | 1 |
| McKay Hart, A | 1 |
| Terenghi, G | 1 |
| Tafti, M | 1 |
| Petit, B | 1 |
| Chollet, D | 1 |
| Neidhart, E | 1 |
| de Bilbao, F | 1 |
| Kiss, JZ | 1 |
| Wood, PA | 1 |
| Franken, P | 1 |
| Levine, J | 1 |
| Kaplan, Z | 1 |
| Pettegrew, JW | 1 |
| McClure, RJ | 1 |
| Gershon, S | 1 |
| Buriakovsky, I | 1 |
| Cohen, H | 1 |
| Rosenthal, RE | 2 |
| Bogaert, YE | 1 |
| Kopke, R | 1 |
| Bielefeld, E | 1 |
| Jackson, R | 1 |
| Henderson, D | 1 |
| Lesnefsky, EJ | 1 |
| He, D | 1 |
| Moghaddas, S | 1 |
| Hoppel, CL | 1 |
| Al-Majed, AA | 1 |
| Sayed-Ahmed, MM | 1 |
| Al-Omar, FA | 1 |
| Al-Yahya, AA | 1 |
| Aleisa, AM | 1 |
| Al-Shabanah, OA | 1 |
| Kotil, K | 1 |
| Kirali, M | 1 |
| Eras, M | 1 |
| Bilge, T | 1 |
| Uzun, H | 1 |
| Elanchezhian, R | 1 |
| Ramesh, E | 1 |
| Sakthivel, M | 1 |
| Isai, M | 1 |
| Geraldine, P | 1 |
| Rajamohan, M | 1 |
| Jesudasan, CN | 1 |
| Thomas, PA | 1 |
| Jin, HW | 1 |
| Flatters, SJ | 1 |
| Mulhern, HL | 1 |
| Martens, ME | 1 |
| Lee, CP | 1 |
| Visentin, M | 1 |
| Bellasio, R | 1 |
| Tacconi, MT | 1 |
| Lolic, MM | 1 |
| El Banani, H | 1 |
| Bernard, M | 1 |
| Cozzone, P | 1 |
| James, F | 1 |
| Feuvray, D | 1 |
| Benzerrouk, R | 1 |
| Qureshi, IA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Repeated Antioxidant Supplementation of Embryo Culture Media on Blastocyst Utilization and Expansion Rate Under Two Different O2 Concentrations[NCT05919186] | 293 participants (Actual) | Interventional | 2021-10-12 | Completed | |||
| Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD:A Randomized, Double Blind, Placebo-controlled, Multicentric Trial.[NCT04284059] | Phase 4 | 504 participants (Anticipated) | Interventional | 2021-02-25 | Recruiting | ||
| Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
| Phase 1 Study of the Safety and Pharmacokinetics of Perioperative IV L-carnitine Administration in Patients With Congenital Heart Disease With Increased Pulmonary Blood Flow[NCT01825369] | Phase 1 | 0 participants (Actual) | Interventional | 2014-12-31 | Withdrawn (stopped due to Changes to cardiac surgery program) | ||
| Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial.[NCT02141035] | Phase 2/Phase 3 | 20 participants (Actual) | Interventional | 2015-09-30 | Completed | ||
| Antioxidation Medication for Noise-induced Hearing Loss[NCT00552786] | Phase 2 | 53 participants (Actual) | Interventional | 2007-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Distortion product otoacoustic emissions (DPOAE) is an objective measure to assess the cochlear changes. DPOAE response threshold at high frequency (HF) was defined as the average of response levels (dB SPL) at 3k,4k,6kHz for each ear examined. A total of four hearing assessments by DPOAE were completed for each formulation period on the 1st day pre- and post-shift, and the 14th day pre- and post-shift. The amount of DPOAE temporary threshold change was calculated by subtracting the pre-shift DPOAE response threshold from the post-shift DPOAE response threshold at each frequency. (NCT00552786)
Timeframe: A total of four hearing assessments were completed for each formulation period on the 1st day pre- and post-shift, and the 14th day pre- and post-shift
| Intervention | decibels (dB SPL) (Mean) |
|---|---|
| N-acetylcysteine (NAC) | -0.85 |
| Placebo | -0.89 |
The hearing threshold level (HL) at high frequency (HF) by pure-tone audiometry (PTA) was defined as the average of HLs at 3k,4k,6kHz for each ear examined. A total of four hearing assessments by PTA were completed for each formulation period on the 1st day pre- and post-shift, and the 14th day pre- and post-shift. The amount of temporary threshold change was calculated by subtracting the pre-shift hearing threshold from the post-shift hearing threshold at each frequency. (NCT00552786)
Timeframe: A total of four hearing assessments were completed for each formulation period on the 1st day pre- and post-shift, and the 14th day pre- and post-shift
| Intervention | decibels (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 3.4 |
| Placebo | 2.7 |
3 reviews available for acetylcarnitine and Disease Models, Animal
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug.
Topics: Acetylcarnitine; Analgesics; Animals; Antidepressive Agents; Chronic Pain; Disease Models, Animal; H | 2017 |
Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
Topics: Acetylcarnitine; Animals; Ascorbic Acid; Biotin; Caffeine; Creatine; Curcumin; Dietary Supplements; | 2018 |
1 trial available for acetylcarnitine and Disease Models, Animal
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
65 other studies available for acetylcarnitine and Disease Models, Animal
| Article | Year |
|---|---|
Acetyl-L-Carnitine Exerts Neuroprotective and Anticonvulsant Effect in Kainate Murine Model of Temporal Lobe Epilepsy.
Topics: Acetylcarnitine; Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocam | 2022 |
Acetyl-L-carnitine improves erectile function in bilateral cavernous nerve injury rats via promoting cavernous nerve regeneration.
Topics: Acetylcarnitine; Animals; Disease Models, Animal; Erectile Dysfunction; Fibrosis; Humans; Male; Nerv | 2022 |
Effects of N-acetylcysteine and acetyl-L-carnitine on acute PTZ-induced seizures in larval and adult zebrafish.
Topics: Acetylcarnitine; Acetylcysteine; Adult; Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; | 2023 |
Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Topics: Acetylcarnitine; Amides; Animals; Carrageenan; Cell Count; Cyclooxygenase 2; Disease Models, Animal; | 2021 |
Effect of acetyl-L-carnitine on hypersensitivity in acute recurrent caerulein-induced pancreatitis and microglial activation along the brain's pain circuitry.
Topics: Acetylcarnitine; Acute Disease; Animals; Brain; Ceruletide; Disease Models, Animal; Male; Mice; Mice | 2021 |
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.
Topics: Acetylcarnitine; Amitriptyline; Analgesics; Animals; Chronic Disease; Disease Models, Animal; Epigen | 2017 |
Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor.
Topics: Acetylcarnitine; Animals; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Inflamma | 2017 |
Antioxidants improve IVF outcome and subsequent embryo development in the mouse.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Antioxidants; Blastocyst; Culture Media; Disease Models, A | 2017 |
Deep Vein Thrombosis Exhibits Characteristic Serum and Vein Wall Metabolic Phenotypes in the Inferior Vena Cava Ligation Mouse Model.
Topics: Acetylcarnitine; Adenosine; Animals; Biomarkers; Chromatography, Liquid; Disease Models, Animal; Ene | 2018 |
Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.
Topics: Acetylcarnitine; Amyotrophic Lateral Sclerosis; Animals; Axonal Transport; Disease Models, Animal; E | 2018 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
Topics: Acetylcarnitine; Adipose Tissue; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransfe | 2013 |
Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
Topics: Acetylcarnitine; Animals; Antioxidants; Behavior, Animal; Brain; Chromatography, Thin Layer; Disease | 2014 |
The effects of N-acetyl-cysteine and acetyl-L-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Antioxidants; Apoptosis; Axons; Cell Survival; Cervical Ve | 2014 |
Acetyl-L-carnitine normalizes the impaired long-term potentiation and spine density in a rat model of global ischemia.
Topics: Acetylcarnitine; Animals; Brain Ischemia; CA1 Region, Hippocampal; Carotid Artery Diseases; Dendriti | 2014 |
Prophylactic role of acetyl-l-carnitine on knee lesions and associated pain in a rat model of osteoarthritis.
Topics: Acetylcarnitine; Animals; Chondrocytes; Disease Models, Animal; Male; Osteoarthritis, Knee; Pain; Pa | 2014 |
Impaired in vivo mitochondrial Krebs cycle activity after myocardial infarction assessed using hyperpolarized magnetic resonance spectroscopy.
Topics: Acetylcarnitine; Animals; Biomarkers; Citric Acid; Citric Acid Cycle; Disease Models, Animal; Female | 2014 |
Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study.
Topics: Acetylcarnitine; Animals; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; | 2015 |
Rapid-acting antidepressant-like effects of acetyl-l-carnitine mediated by PI3K/AKT/BDNF/VGF signaling pathway in mice.
Topics: Acetylcarnitine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chromones; Depre | 2015 |
ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
Topics: Acetylcarnitine; Animals; Antioxidants; Ataxia; Axons; Behavior, Animal; Brain; Cell Nucleus; Diseas | 2016 |
Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
Topics: Acetylcarnitine; Animals; Behavior, Animal; Brain; Cholesterol; Chromatography, Thin Layer; Cognitio | 2015 |
Intrathecal Acetyl-L-Carnitine Protects Tissue and Improves Function after a Mild Contusive Spinal Cord Injury in Rats.
Topics: Acetylcarnitine; Animals; Behavior, Animal; Disease Models, Animal; Female; Infusions, Spinal; Motor | 2016 |
Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine.
Topics: Acetylcarnitine; Aging; Animal Nutritional Physiological Phenomena; Animals; Antioxidants; Coenzymes | 2016 |
Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.
Topics: Acetylcarnitine; Animals; Antidepressive Agents; Dentate Gyrus; Depression; Disease Models, Animal; | 2016 |
Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats.
Topics: Acetylcarnitine; Animals; Animals, Newborn; Behavior, Animal; Disease Models, Animal; Female; Hypoxi | 2016 |
Change in the membranous lipid composition accelerates lipid peroxidation in young rat hearts subjected to 2 weeks of hypoxia followed by hyperoxia.
Topics: Acetylcarnitine; Age Factors; Animals; Antioxidants; Carnitine; Catalase; Cell Membrane; Chronic Dis | 2008 |
Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
Topics: Acetylcarnitine; Animals; Apoptosis; Atropine; Caspase 3; Cytochromes c; Disease Models, Animal; In | 2009 |
Effects of acetylo-L-carnitine in end-to-side neurorrhaphy: a pilot study.
Topics: Acetylcarnitine; Analysis of Variance; Anastomosis, Surgical; Animals; Behavior, Animal; Brachial Pl | 2009 |
The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.
Topics: Acetylcarnitine; Aging; Alzheimer Disease; Animals; Antioxidants; Apolipoprotein E4; Brain; Cerebrov | 2009 |
Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats.
Topics: Acetylcarnitine; Amylases; Animals; Calcium; Ceruletide; Disease Models, Animal; Glutathione; Glutat | 2009 |
Effect of acetyl-L-carnitine on axonal sprouting following donor nerve injury distal to an end-to-side neurorrhaphy model.
Topics: Acetylcarnitine; Animals; Axons; Disease Models, Animal; Electromyography; Male; Motor Endplate; Ner | 2009 |
The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain.
Topics: Acetylcarnitine; Animals; Disease Models, Animal; Enzyme Activation; Functional Laterality; Hyperalg | 2010 |
Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Disease Models, Animal; Hippocampus; Lipid Peroxidat | 2010 |
Oral acetyl-L-carnitine therapy and insulin resistance.
Topics: Acetylcarnitine; Administration, Oral; Animals; Blood Glucose; Cardiovascular Diseases; Diabetes Mel | 2010 |
[Effect of acetyl-L-carnitine on the insulin resistance of L6 cells induced by tumor necrosis factor-alpha].
Topics: Acetylcarnitine; Animals; Cell Line; Disease Models, Animal; Insulin Receptor Substrate Proteins; In | 2010 |
Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L: -carnitine.
Topics: Acetylcarnitine; Alcohols; Animals; Biological Transport; Blood-Aqueous Barrier; Cells, Cultured; Ce | 2011 |
Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain.
Topics: Acetylcarnitine; Animals; Behavior, Animal; Brain; Brain Injuries; Disease Models, Animal; Male; Neu | 2010 |
Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression.
Topics: Acetylcarnitine; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Gene Knockdown | 2011 |
Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Brain | 2011 |
Neurophysiological and morphological responses to treatment with acetyl-L-carnitine in a sciatic nerve injury model: preliminary data.
Topics: Acetylcarnitine; Action Potentials; Animals; Disease Models, Animal; Electromyography; Male; Neural | 2012 |
Selective degeneration of synapses in the dorsal cochlear nucleus of chinchilla following acoustic trauma and effects of antioxidant treatment.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Antioxidants; Auditory Threshold; Biomarkers; Chinchilla; | 2012 |
Preserving mitochondrial function prevents the proteasomal degradation of GTP cyclohydrolase I.
Topics: Acetylcarnitine; Adaptor Proteins, Signal Transducing; Animals; Animals, Newborn; Arginine; Biopteri | 2012 |
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy.
Topics: Acetylcarnitine; Activating Transcription Factor 3; Adenosine Triphosphate; Analysis of Variance; An | 2012 |
Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.
Topics: Acetylcarnitine; Animals; Body Weight; Carbohydrate Metabolism; Cathepsin L; Cytoprotection; Dichlor | 2012 |
Acetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.
Topics: Acetylcarnitine; Animals; Animals, Newborn; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cog | 2012 |
Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Topics: Acetyl-CoA Carboxylase; Acetylcarnitine; Animals; Body Weight; Carnitine O-Palmitoyltransferase; Dis | 2013 |
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Audiometry; Auditory Threshold; Chinchilla; Cochlea; | 2002 |
Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain.
Topics: Acetylcarnitine; Adult; Animals; Brain; Brain Mapping; Cerebral Cortex; Disease Models, Animal; Fati | 2002 |
Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice.
Topics: Acetylcarnitine; Aging; Animals; Avoidance Learning; Brain; Disease Models, Animal; Dose-Response Re | 2002 |
Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment.
Topics: Acetylcarnitine; Animals; Axons; Axotomy; Cell Count; Disease Models, Animal; Immunochemistry; Male; | 2002 |
Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep.
Topics: Acetylcarnitine; Acyl-CoA Dehydrogenase; Animals; Brain; Disease Models, Animal; Electroencephalogra | 2003 |
Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats.
Topics: Acetylcarnitine; Animals; Anti-Anxiety Agents; Anxiety; Arousal; Disease Models, Animal; Dose-Respon | 2005 |
Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Brain Ischemia; Disease Models, Animal; Dogs; Heart | 2005 |
Prevention of impulse noise-induced hearing loss with antioxidants.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Antioxidants; Chinchilla; Disease Models, Animal; Evoked P | 2005 |
Reversal of mitochondrial defects before ischemia protects the aged heart.
Topics: Acetylcarnitine; Aging; Animals; Disease Models, Animal; Heart; L-Lactate Dehydrogenase; Male; Mitoc | 2006 |
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Carnitine; Disease Models, Animal; Energy Metaboli | 2006 |
Neuroprotective effects of acetyl-L-carnithine in experimental chronic compression neuropathy. A prospective, randomized and placebo-control trials.
Topics: Acetylcarnitine; Animals; Axons; Chronic Disease; Decompression, Surgical; Disease Models, Animal; F | 2007 |
Acetyl-L-carnitine prevents selenite-induced cataractogenesis in an experimental animal model.
Topics: Acetylcarnitine; Animals; Antioxidants; Catalase; Cataract; Disease Models, Animal; Electrophoresis, | 2007 |
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.
Topics: Acetylcarnitine; Animals; Axons; Behavior, Animal; Disease Models, Animal; Drug Interactions; Langer | 2008 |
Fatty acid metabolism in skeletal muscle mitochondria from two strains of dystrophic mice.
Topics: Acetylcarnitine; Animals; Carnitine; Carnitine O-Acetyltransferase; Carnitine O-Palmitoyltransferase | 1980 |
Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine.
Topics: Acetylcarnitine; Acyl Coenzyme A; Animals; Aspirin; Carnitine; Coenzyme A; Disease Models, Animal; K | 1995 |
Neuroprotective effects of acetyl-L-carnitine after stroke in rats.
Topics: Acetylcarnitine; Animals; Cerebral Infarction; Disease Models, Animal; Drug Evaluation, Preclinical; | 1997 |
Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury.
Topics: Acetylcarnitine; Animals; Dichloroacetic Acid; Disease Models, Animal; Energy Metabolism; Fatty Acid | 1998 |
Hepatic mitochondrial proteins in congenitally hyperammonemic spf mice: effect of acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Disease Models, Animal; Extracellular Matrix Proteins; Female; Hyperammone | 2001 |